ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH ETANERCEPT-METHOTREXATE THERAPY IN SUBJECTS WITH MODERATELY ACTIVE RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS FROM THE PRESERVE TRIAL

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
Freundlich, Bruce [3 ]
Pavelka, Karel [4 ,5 ]
Nash, Peter [6 ]
Miranda, Pedro [7 ,8 ]
Hammond, Constance [9 ]
Vlahos, Bonnie [9 ]
Pedersen, Ronald [9 ]
Koenig, Andrew S. [9 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Univ Penn, Dept Rheumatol, Philadelphia, PA 19104 USA
[4] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic
[5] Charles Univ Prague, Clin Rheumatol, Prague, Czech Republic
[6] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
[7] Univ Chile, Dept Rheumatol, Santiago, Chile
[8] Hosp San Juan Dios, Santiago, Chile
[9] Pfizer Inc, Dept Specialty Care, Collegeville, PA USA
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：ii12 / ii12
页数：1
相关论文
共 50 条
  • [1] Baseline Predictors of Remission with Combination Etanercept-Methotrexate Therapy in Moderately Active Rheumatoid Arthritis: Interim Results of the PRESERVE Trial
    Smolen, Josef
    Szumski, Annette
    Marshall, Lisa
    Koenig, Andrew S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S474 - S474
  • [2] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON DISEASE ACTIVITY IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS: INTERIM OVERALL AND AUSTRALIAN RESULTS FROM THE PRESERVE TRIAL
    Nash, P.
    Hall, S.
    Will, R.
    Smith, M.
    Buchanan, R.
    Smolen, J.
    Thirunavukkarasu, K.
    Marshall, L.
    Hammond, C.
    Vlahos, B.
    Pedersen, R.
    Koenig, A.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 20 - 20
  • [3] Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
    Josef S. Smolen
    Annette Szumski
    Andrew S. Koenig
    Thomas V. Jones
    Lisa Marshall
    Arthritis Research & Therapy, 20
  • [4] Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
    Smolen, Josef S.
    Szumski, Annette
    Koenig, Andrew S.
    Jones, Thomas V.
    Marshall, Lisa
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [5] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS: AUSTRALIAN RESULTS FROM THE INDUCTION PERIOD OF PRESERVE TRIAL
    Nash, P.
    Hall, S.
    Bird, P.
    Bananis, E.
    Koenig, A.
    Szumski, A.
    Jones, H.
    Kotak, S.
    Witcombe, D.
    Thirunavukkarasu, K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 12 - 13
  • [6] Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study
    Pavelka, Karel
    Szekanecz, Zoltan
    Damjanov, Nemanja
    Majdan, Maria
    Nasonov, Evgeny
    Mazurov, Vadim
    Fabo, Tibor
    Bananis, Eustratios
    Jones, Heather
    Szumski, Annette
    Tang, Boxiong
    Kotak, Sameer
    Koenig, Andrew S.
    Vasilescu, Radu
    CLINICAL RHEUMATOLOGY, 2013, 32 (09) : 1275 - 1281
  • [7] Factors That Impact Work Productivity in the Preserve Trial: A Randomized Controlled Trial of Combination Etanercept-Methotrexate Therapy in Patients with Moderately Active Rheumatoid Arthritis.
    Strand, Vibeke
    Jones, Thomas V.
    Li, Wenzhi
    Koenig, Andrew S.
    Kotak, Sameer
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S777 - S777
  • [8] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN A RANDOMIZED CONTROLLED TRIAL IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS PATIENTS
    Bird, P.
    Wollenhaup, J.
    Lee, S. -H.
    Szekanecz, Z.
    Neira, O.
    Hammond, C.
    Vlahos, B.
    Szumski, A.
    Koenig, A. S.
    Kotak, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 633 - 633
  • [9] RESPONSE TO ETANERCEPT-METHOTREXATE THERAPY AND ETANERCEPT MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH MODERATE AND SEVERE DISEASE IN THE CAMEO TRIAL
    Keystone, E.
    Haraoui, B.
    Thorne, C.
    Poulin-Costello, M.
    Trottier, E.
    Vieira, A.
    Pope, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 425 - 426
  • [10] Impact of Body Mass Index on Response to Etanercept Therapy in Subjects with Moderately Active Rheumatoid Arthritis in the PRESERVE Trial.
    Smolen, Josef S.
    Szumski, Annette
    Koenig, Andrew S.
    Jones, Thomas V.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S154 - S154
12345